Selected research
Market Outlook & Growth Opportunities
Global Ornidazole Capsules Market Outlook and Growth Opportunities 2026
Market perspective
The global Ornidazole Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Ornidazole Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Ornidazole Capsules market include Yangtze River Pharmaceutical Group, Xi'an Wanlong Pharmaceutical Co., Ltd. and Sichuan Baili Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ornidazole Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ornidazole Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ornidazole Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ornidazole Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Ornidazole Capsules Segment by Company
Yangtze River Pharmaceutical Group
Xi'an Wanlong Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Ornidazole Capsules Segment by Type
125mg
250mg
Ornidazole Capsules Segment by Application
Hospital
Clinic
Other
Ornidazole Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Ornidazole Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Ornidazole Capsules market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Ornidazole Capsules significant trends, drivers, influence factors in global and regions.
6. To analyze Ornidazole Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ornidazole Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ornidazole Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ornidazole Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ornidazole Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ornidazole Capsules industry.
Chapter 3: Detailed analysis of Ornidazole Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Ornidazole Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Ornidazole Capsules in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 125mg
- 250mg
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yangtze River Pharmaceutical Group
- Xi'an Wanlong Pharmaceutical Co., Ltd.
- Sichuan Baili Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ornidazole Capsules Sales Value (2021-2032)
- 1.2.2 Global Ornidazole Capsules Sales Volume (2021-2032)
- 1.2.3 Global Ornidazole Capsules Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Ornidazole Capsules Market Dynamics
- 2.1 Ornidazole Capsules Industry Trends
- 2.2 Ornidazole Capsules Industry Drivers
- 2.3 Ornidazole Capsules Industry Opportunities and Challenges
- 2.4 Ornidazole Capsules Industry Restraints
3 Ornidazole Capsules Market by Company
- 3.1 Global Ornidazole Capsules Company Revenue Ranking in 2025
- 3.2 Global Ornidazole Capsules Revenue by Company (2021-2026)
- 3.3 Global Ornidazole Capsules Sales Volume by Company (2021-2026)
- 3.4 Global Ornidazole Capsules Average Price by Company (2021-2026)
- 3.5 Global Ornidazole Capsules Company Ranking (2024-2026)
- 3.6 Global Ornidazole Capsules Company Manufacturing Base and Headquarters
- 3.7 Global Ornidazole Capsules Company Product Type and Application
- 3.8 Global Ornidazole Capsules Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Ornidazole Capsules Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Ornidazole Capsules Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Ornidazole Capsules Market by Type
- 4.1 Ornidazole Capsules Type Introduction
- 4.1.1 125mg
- 4.1.2 250mg
- 4.2 Global Ornidazole Capsules Sales Volume by Type
- 4.2.1 Global Ornidazole Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ornidazole Capsules Sales Volume by Type (2021-2032)
- 4.2.3 Global Ornidazole Capsules Sales Volume Share by Type (2021-2032)
- 4.3 Global Ornidazole Capsules Sales Value by Type
- 4.3.1 Global Ornidazole Capsules Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ornidazole Capsules Sales Value by Type (2021-2032)
- 4.3.3 Global Ornidazole Capsules Sales Value Share by Type (2021-2032)
5 Ornidazole Capsules Market by Application
- 5.1 Ornidazole Capsules Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Ornidazole Capsules Sales Volume by Application
- 5.2.1 Global Ornidazole Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ornidazole Capsules Sales Volume by Application (2021-2032)
- 5.2.3 Global Ornidazole Capsules Sales Volume Share by Application (2021-2032)
- 5.3 Global Ornidazole Capsules Sales Value by Application
- 5.3.1 Global Ornidazole Capsules Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ornidazole Capsules Sales Value by Application (2021-2032)
- 5.3.3 Global Ornidazole Capsules Sales Value Share by Application (2021-2032)
6 Ornidazole Capsules Regional Sales and Value Analysis
- 6.1 Global Ornidazole Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ornidazole Capsules Sales by Region (2021-2032)
- 6.2.1 Global Ornidazole Capsules Sales by Region: 2021-2026
- 6.2.2 Global Ornidazole Capsules Sales by Region (2027-2032)
- 6.3 Global Ornidazole Capsules Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Ornidazole Capsules Sales Value by Region (2021-2032)
- 6.4.1 Global Ornidazole Capsules Sales Value by Region: 2021-2026
- 6.4.2 Global Ornidazole Capsules Sales Value by Region (2027-2032)
- 6.5 Global Ornidazole Capsules Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Ornidazole Capsules Sales Value (2021-2032)
- 6.6.2 North America Ornidazole Capsules Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Ornidazole Capsules Sales Value (2021-2032)
- 6.7.2 Europe Ornidazole Capsules Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Ornidazole Capsules Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Ornidazole Capsules Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Ornidazole Capsules Sales Value (2021-2032)
- 6.9.2 South America Ornidazole Capsules Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Ornidazole Capsules Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Ornidazole Capsules Sales Value Share by Country, 2025 VS 2032
7 Ornidazole Capsules Country-level Sales and Value Analysis
- 7.1 Global Ornidazole Capsules Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Ornidazole Capsules Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Ornidazole Capsules Sales by Country (2021-2032)
- 7.3.1 Global Ornidazole Capsules Sales by Country (2021-2026)
- 7.3.2 Global Ornidazole Capsules Sales by Country (2027-2032)
- 7.4 Global Ornidazole Capsules Sales Value by Country (2021-2032)
- 7.4.1 Global Ornidazole Capsules Sales Value by Country (2021-2026)
- 7.4.2 Global Ornidazole Capsules Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.9.2 France Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.16.2 China Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.19.2 India Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Ornidazole Capsules Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Ornidazole Capsules Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Ornidazole Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Yangtze River Pharmaceutical Group
- 8.1.1 Yangtze River Pharmaceutical Group Company Information
- 8.1.2 Yangtze River Pharmaceutical Group Business Overview
- 8.1.3 Yangtze River Pharmaceutical Group Ornidazole Capsules Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Yangtze River Pharmaceutical Group Ornidazole Capsules Product Portfolio
- 8.1.5 Yangtze River Pharmaceutical Group Recent Developments
- 8.2 Xi'an Wanlong Pharmaceutical Co., Ltd.
- 8.2.1 Xi'an Wanlong Pharmaceutical Co., Ltd. Company Information
- 8.2.2 Xi'an Wanlong Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Xi'an Wanlong Pharmaceutical Co., Ltd. Ornidazole Capsules Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Xi'an Wanlong Pharmaceutical Co., Ltd. Ornidazole Capsules Product Portfolio
- 8.2.5 Xi'an Wanlong Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Sichuan Baili Pharmaceutical Co., Ltd.
- 8.3.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Sichuan Baili Pharmaceutical Co., Ltd. Ornidazole Capsules Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Sichuan Baili Pharmaceutical Co., Ltd. Ornidazole Capsules Product Portfolio
- 8.3.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ornidazole Capsules Value Chain Analysis
- 9.1.1 Ornidazole Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ornidazole Capsules Sales Mode & Process
- 9.2 Ornidazole Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ornidazole Capsules Distributors
- 9.2.3 Ornidazole Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst